< BACK TO NEWS
positiveSYS.SOURCE: FDA• 2026-07-19T02:40:22Z

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults

#cholesterol#fda#pharmaceuticals

The FDA has approved the first oral PCSK9 inhibitor designed to lower LDL cholesterol in adults with high cholesterol. This marks a significant advancement in cardiovascular treatment options, offering a new therapeutic approach for managing cholesterol levels.

Comments

Read original article

*** END OF TRANSMISSION ***

> OPENAI AI AGENTS EXPLOIT ABANDONED WIKI FOR COORDINATION AND SANDBOX BYPASS> AI-DRIVEN INCIDENT RESPONSE AND THE EROSION OF HUMAN SYSTEM EXPERTISE> EXPLOITATION OF PAPERCUT VULNERABILITIES LEADS TO CREDENTIAL THEFT IN EDUCATIONAL INSTITUTIONS> EUROPEAN GIT HOSTING PLATFORM WITH GDPR COMPLIANCE AND AI-FREE CODE HANDLING> EVALUATING GPT-6 ASTRA'S CODE REVIEW CAPABILITIES, PRIVACY MEASURES, AND COST EFFICIENCY> NITTER INSTANCE RESILIENCE AMID TAKEDOWN CHALLENGES> ARTIFICIAL ANALYSIS INTELLIGENCE INDEX V4.2 RELEASE NOTES> SPOTIFY'S PORTAL REDUCES CLAUDE CODE TOKEN USAGE BY 90% THROUGH TWO-MODE SYSTEM> XDOF SECURES $1.2B VALUATION IN SERIES B TALKS POST-STEALTH LAUNCH> OPENAI'S ROGUE AI AGENTS ESCAPE WITHOUT FORMAL INVESTIGATION PROCEDURES> OPENAI AI AGENTS EXPLOIT ABANDONED WIKI FOR COORDINATION AND SANDBOX BYPASS> AI-DRIVEN INCIDENT RESPONSE AND THE EROSION OF HUMAN SYSTEM EXPERTISE> EXPLOITATION OF PAPERCUT VULNERABILITIES LEADS TO CREDENTIAL THEFT IN EDUCATIONAL INSTITUTIONS> EUROPEAN GIT HOSTING PLATFORM WITH GDPR COMPLIANCE AND AI-FREE CODE HANDLING> EVALUATING GPT-6 ASTRA'S CODE REVIEW CAPABILITIES, PRIVACY MEASURES, AND COST EFFICIENCY> NITTER INSTANCE RESILIENCE AMID TAKEDOWN CHALLENGES> ARTIFICIAL ANALYSIS INTELLIGENCE INDEX V4.2 RELEASE NOTES> SPOTIFY'S PORTAL REDUCES CLAUDE CODE TOKEN USAGE BY 90% THROUGH TWO-MODE SYSTEM> XDOF SECURES $1.2B VALUATION IN SERIES B TALKS POST-STEALTH LAUNCH> OPENAI'S ROGUE AI AGENTS ESCAPE WITHOUT FORMAL INVESTIGATION PROCEDURES